For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Level 4 lockdown reading
+News
Level 4 lockdown reading
Tuesday 24 August 2021, 04:17 PM

New Zealand is back in an Alert Level 4 lockdown after a community case of the delta variant of COVID-19 was detected on 17 August
Amy van der Loo rounds up the clinical education content in the latest issue of New Zealand Doctor Rata Aotearoa. Use the embedded links to go through to the relevant page
What we all feared has eventuated – Delta has made its way from our neighbours across the ditch and into our communities, and all while only about 20
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.